Bringing a health care technology to the international market is a challenging process that meets with many international, national and local regulations for registration and reimbursement. Pharmerit's team members have extensive experience with market access and policy research and are familiar with research design, surveys, statistical analysis, strategic planning, and reporting in various disease areas.
In our market acces studies we take many aspects into account that are relevant for the new product, such as the clinical environment, disease burden, unmet need in the current health care, and the health economic environment in which the product will be launched.
The latter assessment provides the context within which messages about the new product's role can be developed, and should ideally identify:
Target product profile
We evaluate the target product profile including assessments of efficacy, safety, effects on quality-of-life and patient reported outcomes, price of the product, mechanism of action, model of administration, dosing, (contra)indications, etcetera. We compare the target product profile with the profile of (potential) competitors.
Our strategic studies often include interviews with stakeholders such as payers, policy makers, physicians and patient organizations. The core interview guides include structured qualitative and semi-quantitative questions for high priority topics. Moreover, the value of the target product profile to payers will be evaluated to identify which attributes are required to achieve success.
We are familiar with the healthcare system and financial structures in many European countries. In the USA we work together with Tag and Associates (www.taghealthcare.com).
Pharmerit has extensive experience in conducting strategic surveys in the global market and we have an international network of key opinion leaders and key decision makers in the clinical and reimbursement field respectively.